About i-SENS
i-SENS is a publicly listed company based in Zhangjiagang (China) founded in 2000. Blood glucose monitoring systems and clinical chemistry analyzers are developed. The company has 81 employees. Its website i-sens.com draws about 63 thousand monthly visits. Its Indian entity Isens Biosensors India Private Limited reported revenue of ₹43.58 Cr. i-SENS offers products and services including CareSens Air App, Blood Glucose Monitoring, Continuous Glucose Monitoring System, Point of Care, and Veterinary Care. Its focus areas include Life Sciences, Diabetes, Medical Devices and Monitoring Devices.
Company details
i-SENS was founded in 2000 and is based in Zhangjiagang, China. Blood glucose monitoring systems, such as the CareSens model for sugar level detection, and clinical chemistry analyzers are produced by the company. A mobile application is provided for users to record and review blood glucose data. Operations center on diagnostic tools within the healthcare sector.
- Headquarters Zhangjiagang, China
- Employees 81
- Stage Public
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website i-sens.com
- Social LinkedIn
- Legal Name Isens Biosensors India Private Limited
- Date of Incorporation 27 Mar, 2015
- Jurisdiction Gurgaon, Haryana, India
- Indian entity revenue₹43.58 Cr
FY 2025 · +21% YoY
- Indian entity net profit₹1.20 Cr
FY 2025 · 3% margin
- Indian entity EBITDA₹2.43 Cr
FY 2025 · 6% margin
- Latest Funding Round$149.9K (USD), Grant
Aug 2014
- Investors
- Employee Count81
Associated legal entities of i-SENS
i-SENS operates through Isens Biosensors India Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Isens Biosensors India Private Limited CIN U74999HR2015PTC055024 | Active | 27 Mar 2015 | Gurgaon, Haryana | ₹43.6 Cr | 81 | 3 | View details |
Products & Services of i-SENS
i-SENS offers a comprehensive portfolio of products and services, including CareSens Air App, Blood Glucose Monitoring, Continuous Glucose Monitoring System, Point of Care, and Veterinary Care.
App for real-time glucose tracking and data sharing.
Devices for measuring blood sugar levels accurately.
System for ongoing glucose level tracking.
Tools for immediate diagnostic testing.
Products for glucose monitoring in animals.
Funding Insights of i-SENS
- Total Rounds 1
- Last Round Grant — $149,902
- First Round $149,902
(Aug 2014)
- Investors Count 1
All 1 funding rounds of i-SENS with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug 2014 | $149,902 | Grant | – | – |
1 investors in total: 1 institutional.
Investors in i-SENS
i-SENS has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include HHS.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Public health and human services are overseen by HHS. | 1953 | hhs.gov |
Investor details for i-SENS
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Isens Biosensors India Private Limited (i-SENS)
Isens Biosensors India Private Limited is the primary company behind i-SENS. The board of Isens Biosensors India Private Limited currently have 3 directors; the longest-serving is Geun Sig Cha, appointed in 2016. 7 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Geun Sig Cha DIN 07565064 | Director | 01 Jul 2016 | 10 yrs 3 mo | Isens Biosensors India Private Limited |
| Manish Mittal DIN 08623009 | Director | 27 Nov 2019 | 6 yrs 10 mo | Isens Biosensors India Private Limited |
| Junghoon Shin DIN 09222589 | Managing Director | 02 Jul 2021 | 5 yrs 3 mo | Isens Biosensors India Private Limited |
People of i-SENS
6 people are tracked at i-SENS (5 in leadership, 1 in team); the tracked headcount is 81.
| Name | Role | Group |
|---|---|---|
Kwang Hyeon Lee | Head Of CGM Division | Leadership |
Hak-Hyun Nam | CEO | Leadership |
Dongjoo Lee | Factory Manager/ Managing Director/ Songdo 2 Factory | Leadership |
Hyun Joon Oh | CPO / Executive Director | Leadership |
Moon Hwan Kim | Director/team Leader | Leadership |
Kyoung Ha Cha | Business Management Team Leader | Team |
Complete people profiles for i-SENS
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of i-SENS
Figures of Isens Biosensors India Private Limited, the primary company behind i-SENS, for FY 2025. Revenue was ₹43.58 Cr (+21% year on year). Net profit was ₹1.20 Cr (3% margin). EBITDA was ₹2.43 Cr (6% margin). Revenue has grown at a compounded annual rate of +13% over three years and +12% over five years.
- ₹43.58 CrRevenue · FY 2025 · +21% YoY
- ₹1.20 CrNet profit · 3% margin
- ₹2.43 CrEBITDA · 6% margin
- ₹8.55 CrPaid-up capital
- 81Employees (provident fund records)
- +13%Revenue CAGR, 3 years
- +12%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Isens Biosensors India Private Limited are on its company page.
Detailed financial statements for i-SENS
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of i-SENS
3 dated milestones of i-SENS across 14 years, from founding to its latest funding, stage changes and deals.
- Founded i-SENS is founded.
- IPO Lists on the stock exchange (IPO).
- Funding First funding round of $150K.
Web traffic of i-SENS
The website of i-SENS (i-sens.com) receives about 63.3K visits a month.
- Monthly visits63.3K
Websites whose visitors overlap most with i-SENS. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
linear.es | linear.es | 100% | #1,370,338 | – | |
| boditech.co.kr | 100% | 21.1K | #839,612 | View details | |
mediq.fi | mediq.fi | 91% | #6,552,199 | – | |
glucorx.co.uk | glucorx.co.uk | 85% | #1,229,062 | – | |
jhewitt.com | jhewitt.com | 72% | – | ||
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 15 similar websites and full traffic analytics for i-SENS
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 15 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about I-Sens
Complete news archive for i-SENS
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about i-SENS
i-SENS was founded in 2000 and raised its 1st funding round 14 years after it was founded.
i-SENS is headquartered in Zhangjiagang, China. It is registered at Zhangjiagang, Jiangsu, China.
i-SENS has 81 employees.
The primary company behind i-SENS, Isens Biosensors India Private Limited, reported revenue of ₹43.58 Cr for FY 2025, up 21% year on year.
i-SENS was founded in 2000 and is based in Zhangjiagang, China. Blood glucose monitoring systems, such as the CareSens model for sugar level detection, and clinical chemistry analyzers are produced by the company. A mobile application is provided for users to record and review blood glucose data. Operations center on diagnostic tools within the healthcare sector.
i-SENS offers CareSens Air App, Blood Glucose Monitoring, Continuous Glucose Monitoring System, Point of Care, and Veterinary Care.
i-SENS has 1 investor. Key investors include HHS.
i-SENS operates through Isens Biosensors India Private Limited.
The legal entities of i-SENS currently have 3 directors, including Junghoon Shin, Manish Mittal, Geun Sig Cha.